REGISTERED NUMBER: 03848523 (England and Wales)

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MARCH 2025

FOR

C D & J H MEDICAL LIMITED

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr C D Heath

Mrs J Heath

Mrs K J Heath

Dr C J Heath

REGISTERED OFFICE:

c/o Michael Heaven & Associates Limited

47 Calthorpe Road

Edgbaston

BIRMINGHAM

West Midlands

B15 1TH

REGISTERED NUMBER:

03848523 (England and Wales)

ACCOUNTANTS:

Michael Heaven & Associates Limited

Chartered Certified Accountants

47 Calthorpe Road

Edgbaston

BIRMINGHAM

B15 1TH

INCORPORATION:

27th September 1999

FIXED ASSETS

Tangible assets

4

16,505

20,631

Investments

5

19,102

19,102

35,607

39,733

CURRENT ASSETS

Debtors

31,794

23,363

Cash at bank

98,165

93,657

129,959

117,020

CREDITORS

Amounts falling due within one year

70,410

86,741

NET CURRENT ASSETS

59,549

30,279

TOTAL ASSETS LESS CURRENT LIABILITIES

95,156

70,012

PROVISIONS FOR LIABILITIES

6

4,374

5,467

NET ASSETS

90,782

64,545

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

90,682

64,445

SHAREHOLDERS' FUNDS

90,782

64,545

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31st March 2025 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21st November 2025 and were signed on its behalf by:

Dr C D Heath - Director

1.	STATUTORY INFORMATION

C D & J H Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents the value of services provided to the extent that there is a right to consideration and is recorded at the value of the consideration due.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

20% on reducing balance

Motor vehicles

-

20% on reducing balance

Financial instruments

The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, and loans from related parties.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Debtors

Short term debtors are measured at transaction price, less any impairment.

Creditors

Short term trade creditors are measured at the transaction price.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1st April 2024

and 31st March 2025

50,693

DEPRECIATION

At 1st April 2024

30,062

Charge for year

4,126

At 31st March 2025

34,188

NET BOOK VALUE

At 31st March 2025

16,505

At 31st March 2024

20,631

5.	FIXED ASSET INVESTMENTS

Information on investments other than loans is as follows:

Totals

£

COST

At 1st April 2024

and 31st March 2025

19,102

NET BOOK VALUE

At 31st March 2025

19,102

At 31st March 2024

19,102

The company owns shares in Bromsgrove Healthcare Innovations Limited. A reliable valuation for the shares at the balance sheet date is not available.

6.	PROVISIONS FOR LIABILITIES

2025

2024

£

£

Deferred tax

4,374

5,467

Deferred

tax

£

Balance at 1st April 2024

5,467

Movement

(1,093

)

Balance at 31st March 2025

4,374

Provisions are recognised when the company has a legal or constructive obligation at the reporting date as a result of a past event, it is probable that the company will be required to settle the obligation and the amount of the obligation can be reliably estimated.

Provisions are recognised at the best estimate of the amount required to settle the obligation at the reporting date.

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

10

Ordinary A

£1

10

10

34

Ordinary B

£1

34

34

33

Ordinary C

£1

33

33

23

Ordinary D

£1

23

23

100

100

8.	RELATED PARTY DISCLOSURES

As at the year end the amount due to the directors totalled £42,149 (2024- £64,107). The loans are interest free and repayable on demand.